Financing, Equity Private Placements

CereVasc, Inc.

05/24
|
$70.0 Million
CereVasc
Bain
Xontogeny
Piper Sandler served as sole financial advisor for CereVasc, Inc. on a Series B Financing from Bain Capital Life Sciences and Perceptive Xontogeny Venture Fund (PXV)
Sub-Type
Minority Capital Raise
Sub-Sector
Med-Tech